Application

19612712 · LEVERAGING CANCER-EVOLVED RESISTANCE MECHANISMS TO ENHANCE EZH2 ACTIVITY IN ADOPTIVE T CELLS

Filed 2026-08-05 · Pending The official file ↗ · Art unit · BIOVENTURES, LLC · QUARLES & BRADY LLP

Office actions

first was

RCEs

no appeal

To first action

n/a

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.